About us
Careers
Contact
AI-Immunology™
Pioneer™ & ObsERV™
Eden™
Raven™
Pipeline
Product candidates
R&D
AI Immuno-Informatics
Laboratories
Animal Facility
Translational Medicine
Vaccine Manufacturing
Clinical Development
Partnerships
Partner with us
Our partnerships
Media
Press releases
Publications
Presentations
Investors
Evaxion shares
Reports & Filings
Corporate Governance
FAQ
Media
SEARCH
Menu
About us
AI-Immunology™
Pipeline
R&D
Partnerships
Media
Investors
About Us
Careers
Contact
Back
AI-Immunology™
Pioneer™ & ObsERV™
Eden™
Raven™
Back
Pipeline
Product candidates
Back
R&D
AI Immuno-Informatics
Laboratories
Animal Facility
Translational Medicine
Vaccine Manufacturing
Clinical Development
Back
Partnerships
Partner with us
Our partnerships
Back
Media
Press releases
Publications
Presentations
Back
Investors
Evaxion shares
Reports & Filings
Corporate Governance
FAQ
Media
Back
SEARCH
Presentation
Get to know CEO Per Norlén
Redeye interviewed Evaxion’s newly appointed CEO, Per Norlén, about his background, reasons for joining the company, and hopes for the future.
By Redeye
Watch the interview